TreeWAS – Variant ID: rs12554707

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N83.0 Follicular cyst of ovary	0.000	0.989	0.011
R07.3 Other chest pain	0.000	0.992	0.008
K29.4 Chronic atrophic gastritis	0.000	0.994	0.006
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.995	0.005
E27.9 Disorder of adrenal gland, unspecified	0.005	0.995	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.996	0.004
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.996	0.004
T43.2 Other and unspecified antidepressants	0.000	0.996	0.004
E27 Other disorders of adrenal gland	0.004	0.996	0.000
E27.1 Primary adrenocortical insufficiency	0.004	0.996	0.000
E23.0 Hypopituitarism	0.004	0.996	0.000
E27.2 Addisonian crisis	0.004	0.996	0.000
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.996	0.004
E27.8 Other specified disorders of adrenal gland	0.004	0.996	0.000
N83.1 Corpus luteum cyst	0.000	0.996	0.004
E23 Hypofunction and other disorders of pituitary gland	0.004	0.996	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.997	0.003
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
T43.6 Psychostimulants with abuse potential	0.000	0.997	0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.003
S61.8 Open wound of other parts of wrist and hand	0.000	0.997	0.003
E27.5 Adrenomedullary hyperfunction	0.003	0.997	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.003	0.997	0.000
E27.0 Other adrenocortical overactivity	0.003	0.997	0.000
T84.8 Other complications of internal orthopaedic prosthetic devices, implants and grafts	0.003	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.003
E05.9 Thyrotoxicosis, unspecified	0.000	0.997	0.003
S22.00 Fracture of thoracic vertebra (closed)	0.003	0.997	0.000
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified	0.000	0.997	0.003
N70.1 Chronic salpingitis and oophoritis	0.003	0.997	0.000
E23.6 Other disorders of pituitary gland	0.003	0.997	0.000
E23.2 Diabetes insipidus	0.003	0.997	0.000
N83.7 Haematoma of broad ligament	0.000	0.997	0.003
N83.6 Haematosalpinx	0.000	0.997	0.003
N83.5 Torsion of ovary, ovarian pedicle and Fallopian tube	0.000	0.997	0.003
N83.4 Prolapse and hernia of ovary and Fallopian tube	0.000	0.997	0.003
N83.2 Other and unspecified ovarian cysts	0.000	0.997	0.003
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.003
H53.4 Visual field defects	0.003	0.997	0.000
E23.7 Disorder of pituitary gland, unspecified	0.003	0.997	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.003	0.997	0.000
E23.1 Drug-induced hypopituitarism	0.003	0.997	0.000
G35 Multiple sclerosis	0.000	0.997	0.003
E11.4 With neurological complications	0.003	0.997	0.000
N83.3 Acquired atrophy of ovary and Fallopian tube	0.000	0.997	0.003
J84.1 Other interstitial pulmonary diseases with fibrosis	0.000	0.997	0.003
E20-E35 Disorders of other endocrine glands	0.003	0.997	0.000
M81.98 Osteoporosis, unspecified (Other)	0.000	0.997	0.003
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.002	0.997	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.000	0.997	0.003
R01.1 Cardiac murmur, unspecified	0.003	0.997	0.000
E22 Hyperfunction of pituitary gland	0.002	0.997	0.000
G59.0 Diabetic mononeuropathy	0.002	0.998	0.000
M25.61 Stiffness of joint, not elsewhere classified (Shoulder region)	0.002	0.998	0.000
E34 Other endocrine disorders	0.002	0.998	0.000
E34.8 Other specified endocrine disorders	0.002	0.998	0.000
N47 Redundant prepuce, phimosis and paraphimosis	0.000	0.998	0.002
E22.0 Acromegaly and pituitary gigantism	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.998	0.002
E34.0 Carcinoid syndrome	0.002	0.998	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.002	0.998	0.000
E32 Diseases of thymus	0.002	0.998	0.000
E31 Polyglandular dysfunction	0.002	0.998	0.000
E30 Disorders of puberty, not elsewhere classified	0.002	0.998	0.000
E25 Adrenogenital disorders	0.002	0.998	0.000
E20 Hypoparathyroidism	0.002	0.998	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.002	0.998	0.000
E22.8 Other hyperfunction of pituitary gland	0.002	0.998	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.002	0.998	0.000
J84 Other interstitial pulmonary diseases	0.000	0.998	0.002
I12.9 Hypertensive renal disease without renal failure	0.002	0.998	0.000
E34.5 Androgen resistance syndrome	0.002	0.998	0.000
E34.4 Constitutional tall stature	0.002	0.998	0.000
E34.3 Short stature, not elsewhere classified	0.002	0.998	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.002	0.998	0.000
E34.1 Other hypersecretion of intestinal hormones	0.002	0.998	0.000
E24 Cushing's syndrome	0.002	0.998	0.000
E26 Hyperaldosteronism	0.002	0.998	0.000
I12.0 Hypertensive renal disease with renal failure	0.002	0.998	0.000
S22.0 Fracture of thoracic vertebra	0.002	0.998	0.000
H44.2 Degenerative myopia	0.002	0.998	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.000	0.998	0.002
E11.8 With unspecified complications	0.002	0.998	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
D23.5 Skin of trunk	0.002	0.998	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.998	0.002
D46.9 Myelodysplastic syndrome, unspecified	0.000	0.998	0.002
T50.8 Diagnostic agents	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
T50.5 Appetite depressants	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.002
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.998	0.002
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.002
E20.8 Other hypoparathyroidism	0.002	0.998	0.000
E20.1 Pseudohypoparathyroidism	0.002	0.998	0.000
E20.0 Idiopathic hypoparathyroidism	0.002	0.998	0.000
E20.9 Hypoparathyroidism, unspecified	0.002	0.998	0.000
E25.9 Adrenogenital disorder, unspecified	0.002	0.998	0.000
E25.8 Other adrenogenital disorders	0.002	0.998	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.002	0.998	0.000
E30.9 Disorder of puberty, unspecified	0.002	0.998	0.000
E30.8 Other disorders of puberty	0.002	0.998	0.000
E30.1 Precocious puberty	0.002	0.998	0.000
E30.0 Delayed puberty	0.002	0.998	0.000
E31.9 Polyglandular dysfunction, unspecified	0.002	0.998	0.000
E31.8 Other polyglandular dysfunction	0.002	0.998	0.000
E31.1 Polyglandular hyperfunction	0.002	0.998	0.000
E31.0 Autoimmune polyglandular failure	0.002	0.998	0.000
E32.9 Disease of thymus, unspecified	0.002	0.998	0.000
E32.8 Other diseases of thymus	0.002	0.998	0.000
E32.1 Abscess of thymus	0.002	0.998	0.000
E32.0 Persistent hyperplasia of thymus	0.002	0.998	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.002	0.998	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.002	0.998	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.002	0.998	0.000
E29 Testicular dysfunction	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
S91.3 Open wound of other parts of foot	0.002	0.998	0.000
E24.2 Drug-induced Cushing's syndrome	0.002	0.998	0.000
E34.9 Endocrine disorder, unspecified	0.002	0.998	0.000
J84.0 Alveolar and parietoalveolar conditions	0.000	0.998	0.002
E22.1 Hyperprolactinaemia	0.001	0.998	0.000
E24.8 Other Cushing's syndrome	0.001	0.998	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.001	0.998	0.000
E24.3 Ectopic ACTH syndrome	0.001	0.998	0.000
E24.1 Nelson's syndrome	0.001	0.998	0.000
E24.0 Pituitary-dependent Cushing's disease	0.001	0.998	0.000
E26.9 Hyperaldosteronism, unspecified	0.001	0.998	0.000
E26.8 Other hyperaldosteronism	0.001	0.998	0.000
E26.1 Secondary hyperaldosteronism	0.001	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.998	0.002
R07.1 Chest pain on breathing	0.000	0.998	0.002
U89.8 Agent resistant to other single specified antibiotic	0.000	0.998	0.002
S22.01 Fracture of thoracic vertebra (open)	0.002	0.998	0.000
T40.6 Other and unspecified narcotics	0.000	0.998	0.002
T83.1 Mechanical complication of other urinary devices and implants	0.000	0.998	0.002
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.998	0.002
E28 Ovarian dysfunction	0.001	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.002
K63.8 Other specified diseases of intestine	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
E05.5 Thyroid crisis or storm	0.000	0.998	0.001
E05.4 Thyrotoxicosis factitia	0.000	0.998	0.001
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.998	0.001
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.998	0.001
N81.3 Complete uterovaginal prolapse	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.001
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.001
T38.7 Androgens and anabolic congeners	0.000	0.998	0.001
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.001
T38.5 Other oestrogens and progestogens	0.000	0.998	0.001
T38.4 Oral contraceptives	0.000	0.998	0.001
T38.2 Antithyroid drugs	0.000	0.998	0.001
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.001
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.001
T39.1 4-Aminophenol derivatives	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
E11 Non-insulin-dependent diabetes mellitus	0.002	0.998	0.000
S32.50 Fracture of pubis (closed)	0.002	0.998	0.000
E11.5 With peripheral circulatory complications	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.001
T36.8 Other systemic antibiotics	0.000	0.998	0.001
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.001
T36.6 Rifamycins	0.000	0.998	0.001
T36.5 Aminoglycosides	0.000	0.998	0.001
T36.4 Tetracyclines	0.000	0.998	0.001
T36.3 Macrolides	0.000	0.998	0.001
T36.2 Chloramphenicol group	0.000	0.998	0.001
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.001
T36.0 Penicillins	0.000	0.998	0.001
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.001
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.001
T37.5 Antiviral drugs	0.000	0.998	0.001
T37.4 Anthelminthics	0.000	0.998	0.001
T37.3 Other antiprotozoal drugs	0.000	0.998	0.001
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.001
T37.1 Antimycobacterial drugs	0.000	0.998	0.001
T37.0 Sulphonamides	0.000	0.998	0.001
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.001
T39.2 Pyrazolone derivatives	0.000	0.998	0.001
T41.5 Therapeutic gases	0.000	0.998	0.001
T41.4 Anaesthetic, unspecified	0.000	0.998	0.001
T41.3 Local anaesthetics	0.000	0.998	0.001
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.001
T41.1 Intravenous anaesthetics	0.000	0.998	0.001
T41.0 Inhaled anaesthetics	0.000	0.998	0.001
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.001
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.001
T48.5 Anti-common-cold drugs	0.000	0.998	0.001
T48.4 Expectorants	0.000	0.998	0.001
T48.3 Antitussives	0.000	0.998	0.001
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.001
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.001
T48.0 Oxytocic drugs	0.000	0.998	0.001
T49.9 Topical agent, unspecified	0.000	0.998	0.001
T49.8 Other topical agents	0.000	0.998	0.001
T49.7 Dental drugs, topically applied	0.000	0.998	0.001
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.001
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.001
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.001
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.001
T49.2 Local astringents and local detergents	0.000	0.998	0.001
T49.1 Antipruritics	0.000	0.998	0.001
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.001
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.001
U80 Agent resistant to penicillin and related antibiotics	0.000	0.998	0.002
M62.85 Other specified disorders of muscle (Pelvic region and thigh)	0.002	0.998	0.000
G62.9 Polyneuropathy, unspecified	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.000	0.998	0.001
T42.1 Iminostilbenes	0.000	0.998	0.001
I12 Hypertensive renal disease	0.002	0.998	0.000
E05.8 Other thyrotoxicosis	0.000	0.998	0.001
U51 Admission status on psychiatric patients	0.000	0.998	0.002
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.002	0.998	0.000
E26.0 Primary hyperaldosteronism	0.001	0.998	0.000
E29.9 Testicular dysfunction, unspecified	0.001	0.998	0.000
E29.8 Other testicular dysfunction	0.001	0.998	0.000
E29.0 Testicular hyperfunction	0.001	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.001
T40.8 Lysergide [LSD]	0.000	0.998	0.001
T40.7 Cannabis (derivatives)	0.000	0.998	0.001
T40.5 Cocaine	0.000	0.998	0.001
T40.3 Methadone	0.000	0.998	0.001
T40.1 Heroin	0.000	0.998	0.001
T40.0 Opium	0.000	0.998	0.001
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.001
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.001
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.001
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.001
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.001
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.001
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.001
T44.0 Anticholinesterase agents	0.000	0.998	0.001
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.001
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.001
T47.7 Emetics	0.000	0.998	0.001
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.001
T47.5 Digestants	0.000	0.998	0.001
T47.4 Other laxatives	0.000	0.998	0.001
T47.3 Saline and osmotic laxatives	0.000	0.998	0.001
T47.2 Stimulant laxatives	0.000	0.998	0.001
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.001
J84.8 Other specified interstitial pulmonary diseases	0.000	0.998	0.001
T46.1 Calcium-channel blockers	0.000	0.998	0.001
Z43.1 Attention to gastrostomy	0.002	0.998	0.000
G97.1 Other reaction to spinal and lumbar puncture	0.001	0.998	0.000
I22.9 Subsequent myocardial infarction of unspecified site	0.000	0.998	0.002
T88.7 Unspecified adverse effect of drug or medicament	0.000	0.998	0.001
Z93.1 Gastrostomy status	0.002	0.998	0.000
N70 Salpingitis and oophoritis	0.001	0.998	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.998	0.001
E24.9 Cushing's syndrome, unspecified	0.001	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.998	0.001
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.998	0.001
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.998	0.001
T42.3 Barbiturates	0.000	0.998	0.001
T42.2 Succinimides and oxazolidinediones	0.000	0.998	0.001
T42.0 Hydantoin derivatives	0.000	0.998	0.001
E11.2 With renal complications	0.001	0.999	0.000
E11.0 With coma	0.001	0.999	0.000
E21.0 Primary hyperparathyroidism	0.000	0.999	0.001
T39.0 Salicylates	0.000	0.999	0.001
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.999	0.001
U80.0 Penicillin resistant agent	0.000	0.999	0.001
M90.75 Fracture of bone in neoplastic disease (Pelvic region and thigh)	0.001	0.999	0.000
E28.9 Ovarian dysfunction, unspecified	0.001	0.999	0.000
E28.8 Other ovarian dysfunction	0.001	0.999	0.000
E28.1 Androgen excess	0.001	0.999	0.000
E28.0 Oestrogen excess	0.001	0.999	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.999	0.001
T42.4 Benzodiazepines	0.000	0.999	0.001
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.999	0.001
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.999	0.001
T46.7 Peripheral vasodilators	0.000	0.999	0.001
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.999	0.001
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.999	0.001
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.999	0.001
Z03.5 Observation for other suspected cardiovascular diseases	0.000	0.999	0.001
E11.7 With multiple complications	0.001	0.999	0.000
T45.5 Anticoagulants	0.000	0.999	0.001
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.999	0.001
U89 Agent resistant to other and unspecified antibiotics	0.000	0.999	0.001
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.999	0.001
E53.8 Deficiency of other specified B group vitamins	0.001	0.999	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.999	0.001
T45.8 Other primarily systemic and haematological agents	0.000	0.999	0.001
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.999	0.001
T45.6 Fibrinolysis-affecting drugs	0.000	0.999	0.001
T45.4 Iron and its compounds	0.000	0.999	0.001
T45.3 Enzymes, not elsewhere classified	0.000	0.999	0.001
T45.2 Vitamins, not elsewhere classified	0.000	0.999	0.001
I44.3 Other and unspecified atrioventricular block	0.000	0.999	0.001
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.999	0.001
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.999	0.001
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.999	0.001
Z43.0 Attention to tracheostomy	0.001	0.999	0.000
M80.50 Idiopathic osteoporosis with pathological fracture (Multiple sites)	0.001	0.999	0.000
E11.6 With other specified complications	0.001	0.999	0.000
E11.1 With ketoacidosis	0.001	0.999	0.000
E28.3 Primary ovarian failure	0.001	0.999	0.000
H44.8 Other disorders of globe	0.001	0.999	0.000
R30.9 Painful micturition, unspecified	0.001	0.999	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.999	0.001
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.999	0.001
G35-G37 Demyelinating diseases of the central nervous system	0.000	0.999	0.001
M62.86 Other specified disorders of muscle (Lower leg)	0.001	0.999	0.000
N70.0 Acute salpingitis and oophoritis	0.001	0.999	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.001	0.999	0.001
N70.9 Salpingitis and oophoritis, unspecified	0.001	0.999	0.000
Z03.1 Observation for suspected malignant neoplasm	0.001	0.999	0.000
M62.8 Other specified disorders of muscle	0.001	0.999	0.000
Y42.5 Other oestrogens and progestogens	0.001	0.999	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.999	0.001
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.999	0.001
T88.6 Anaphylactic shock due to adverse effect of correct drug or medicament properly administered	0.000	0.999	0.001
U89.9 Agent resistant to unspecified antibiotic	0.000	0.999	0.001
Z93.3 Colostomy status	0.001	0.999	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.999	0.001
U50 Level of care administered to neonates	0.000	0.999	0.001
U07 Emergency use of U07	0.000	0.999	0.001
U06 Emergency use of U06	0.000	0.999	0.001
U04 Severe acute respiratory syndrome [SARS]	0.000	0.999	0.001
U52 First in a series of a regular day/night admissions	0.000	0.999	0.001
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)	0.001	0.999	0.000
M62.81 Other specified disorders of muscle (Shoulder region)	0.001	0.999	0.000
C18.9 Colon, unspecified	0.001	0.999	0.000
E11.3 With ophthalmic complications	0.001	0.999	0.000
I44.6 Other and unspecified fascicular block	0.000	0.999	0.001
R07 Pain in throat and chest	0.000	0.999	0.001
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.999	0.001
G37 Other demyelinating diseases of central nervous system	0.000	0.999	0.001
H44 Disorders of globe	0.001	0.999	0.000
M62.88 Other specified disorders of muscle (Other)	0.001	0.999	0.000
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.001	0.999	0.000
C91.1 Chronic lymphocytic leukaemia	0.000	0.999	0.001
E13.9 Without complications	0.001	0.999	0.000
G36 Other acute disseminated demyelination	0.000	0.999	0.001
M40.29 Other and unspecified kyphosis (Site unspecified)	0.001	0.999	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.001	0.999	0.001
E21.4 Other specified disorders of parathyroid gland	0.001	0.999	0.001
E21.2 Other hyperparathyroidism	0.001	0.999	0.001
E28.2 Polycystic ovarian syndrome	0.000	0.999	0.001
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system	0.000	0.999	0.001
I45.5 Other specified heart block	0.001	0.999	0.000
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.999	0.001
Z22.3 Carrier of other specified bacterial diseases	0.000	0.999	0.001
M62.87 Other specified disorders of muscle (Ankle and foot)	0.001	0.999	0.000
M62.84 Other specified disorders of muscle (Hand)	0.001	0.999	0.000
M62.83 Other specified disorders of muscle (Forearm)	0.001	0.999	0.000
C18.0 Caecum	0.001	0.999	0.000
E29.1 Testicular hypofunction	0.001	0.999	0.001
H44.1 Other endophthalmitis	0.001	0.999	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.999	0.001
U80.1 Methicillin resistant agent	0.000	0.999	0.001
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.001	0.999	0.000
M62.89 Other specified disorders of muscle (Site unspecified)	0.001	0.999	0.000
M62.82 Other specified disorders of muscle (Upper arm)	0.001	0.999	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.000	0.999	0.001
U06.9 Emergency use of U06.9	0.000	0.999	0.001
U06.8 Emergency use of U06.8	0.000	0.999	0.001
U06.7 Emergency use of U06.7	0.000	0.999	0.001
U06.6 Emergency use of U06.6	0.000	0.999	0.001
U06.5 Emergency use of U06.5	0.000	0.999	0.001
U06.4 Emergency use of U06.4	0.000	0.999	0.001
U06.3 Emergency use of U06.3	0.000	0.999	0.001
U06.2 Emergency use of U06.2	0.000	0.999	0.001
U06.1 Emergency use of U06.1	0.000	0.999	0.001
U06.0 Emergency use of U06.0	0.000	0.999	0.001
U07.9 Emergency use of U07.9	0.000	0.999	0.001
U07.8 Emergency use of U07.8	0.000	0.999	0.001
U07.7 Emergency use of U07.7	0.000	0.999	0.001
U07.6 Emergency use of U07.6	0.000	0.999	0.001
U07.5 Emergency use of U07.5	0.000	0.999	0.001
U07.4 Emergency use of U07.4	0.000	0.999	0.001
U07.3 Emergency use of U07.3	0.000	0.999	0.001
U07.2 Emergency use of U07.2	0.000	0.999	0.001
U07.1 Emergency use of U07.1	0.000	0.999	0.001
U07.0 Emergency use of U07.0	0.000	0.999	0.001
U50.9 Inquest Adjourned Death	0.000	0.999	0.001
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.000	0.999	0.001
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.000	0.999	0.001
U50.1 Level of care administered to neonates (Special Care)	0.000	0.999	0.001
U50.0 Level of care administered to neonates (Normal Care)	0.000	0.999	0.001
U81.8 Agent resistant to other vancomycin-related antibiotic	0.000	0.999	0.001
U81.0 Vancomycin resistant agent	0.000	0.999	0.001
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.000	0.999	0.001
S72.00 Fracture of neck of femur (closed)	0.001	0.999	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.001	0.999	0.001
G95.9 Disease of spinal cord, unspecified	0.001	0.999	0.000
H44.9 Disorder of globe, unspecified	0.001	0.999	0.000
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.001	0.999	0.000
H44.6 Retained (old) intraocular foreign body, magnetic	0.001	0.999	0.000
H44.5 Degenerated conditions of globe	0.001	0.999	0.000
H44.4 Hypotony of eye	0.001	0.999	0.000
H44.3 Other degenerative disorders of globe	0.001	0.999	0.000
N93.9 Abnormal uterine and vaginal bleeding, unspecified	0.000	0.999	0.001
S32.5 Fracture of pubis	0.001	0.999	0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.001	0.999	0.000
G37.8 Other specified demyelinating diseases of central nervous system	0.000	0.999	0.001
G37.5 Concentric sclerosis [Balo]	0.000	0.999	0.001
G37.4 Subacute necrotising myelitis	0.000	0.999	0.001
G37.2 Central pontine myelinolysis	0.000	0.999	0.001
G37.1 Central demyelination of corpus callosum	0.000	0.999	0.001
G37.0 Diffuse sclerosis	0.000	0.999	0.001
H25.0 Senile incipient cataract	0.001	0.999	0.000
T88.8 Other specified complications of surgical and medical care, not elsewhere classified	0.000	0.999	0.001
M46.18 Sacroiliitis, not elsewhere classified-Sacral/sacrococ	0.001	0.999	0.000
M81.40 Drug-induced osteoporosis (Multiple sites)	0.000	0.999	0.001
G36.9 Acute disseminated demyelination, unspecified	0.000	0.999	0.001
G36.8 Other specified acute disseminated demyelination	0.000	0.999	0.001
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]	0.000	0.999	0.001
G36.0 Neuromyelitis optica [Devic]	0.000	0.999	0.001
T40.2 Other opioids	0.000	0.999	0.001
Z45.8 Adjustment and management of other implanted devices	0.000	0.999	0.001
Z47.0 Follow-up care involving removal of fracture plate and other internal fixation device	0.000	0.999	0.001
U88 Agent resistant to multiple antibiotics	0.000	0.999	0.001
M40.24 Other and unspecified kyphosis (Thoracic region)	0.001	0.999	0.000
S51.8 Open wound of other parts of forearm	0.001	0.999	0.000
Z43.6 Attention to other artificial openings of urinary tract	0.001	0.999	0.000
U84 Resistance to other antimicrobial drugs	0.000	0.999	0.001
U83 Resistance to other antibiotics	0.000	0.999	0.001
U82 Resistance to betalactam antibiotics	0.000	0.999	0.001
U85 Resistance to antineoplastic drugs	0.000	0.999	0.001
S32.51 Fracture of pubis (open)	0.001	0.999	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.001	0.999	0.000
M46.9 Inflammatory spondylopathy, unspecified	0.001	0.999	0.000
Q15.0 Congenital glaucoma	0.001	0.999	0.000
Q76.0 Spina bifida occulta	0.001	0.999	0.000
R27.0 Ataxia, unspecified	0.001	0.999	0.000
S30.1 Contusion of abdominal wall	0.001	0.999	0.000
Z80.9 Family history of malignant neoplasm, unspecified	0.001	0.999	0.000
G59 Mononeuropathy in diseases classified elsewhere	0.001	0.999	0.000
S52.10 Fracture of upper end of radius (closed)	0.001	0.999	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.001	0.999	0.000
H73.8 Other specified disorders of tympanic membrane	0.000	0.999	0.001
M80.5 Idiopathic osteoporosis with pathological fracture	0.001	0.999	0.000
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.000	0.999	0.001
Q65.8 Other congenital deformities of hip	0.001	0.999	0.000
Q89.2 Congenital malformations of other endocrine glands	0.001	0.999	0.000
Z95.1 Presence of aortocoronary bypass graft	0.000	0.999	0.001
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.001	0.999	0.000
G37.9 Demyelinating disease of central nervous system, unspecified	0.000	0.999	0.001
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.999	0.001
U82.9 Resistance to betalactam antibiotics, unspecified	0.000	0.999	0.001
U82.8 Resistance to other betalactam antibiotics	0.000	0.999	0.001
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.000	0.999	0.001
U82.1 Resistance to methicillin	0.000	0.999	0.001
U82.0 Resistance to penicillin	0.000	0.999	0.001
U83.9 Resistance to unspecified antibiotic	0.000	0.999	0.001
U83.8 Resistance to other single specified antibiotic	0.000	0.999	0.001
U83.7 Resistance to multiple antibiotics	0.000	0.999	0.001
U83.2 Resistance to quinolones	0.000	0.999	0.001
U83.1 Resistance to other vancomycin related antibiotics	0.000	0.999	0.001
U83.0 Resistance to vancomycin	0.000	0.999	0.001
U84.9 Resistance to unspecified antimicrobial drugs	0.000	0.999	0.001
U84.8 Resistance to other specified antimicrobial drug	0.000	0.999	0.001
U84.7 Resistance to multiple antimicrobial drugs	0.000	0.999	0.001
U84.3 Resistance to tuberculostatic drug(s)	0.000	0.999	0.001
U84.2 Resistance to antiviral drug(s)	0.000	0.999	0.001
U84.1 Resistance to antifungal drug(s)	0.000	0.999	0.001
U84.0 Resistance to antiparasitic drug(s)	0.000	0.999	0.001
Y42.7 Androgens and anabolic congeners	0.001	0.999	0.000
M40.26 Other and unspecified kyphosis (Lumbar region)	0.001	0.999	0.000
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.001	0.999	0.000
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)	0.001	0.999	0.000
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)	0.001	0.999	0.000
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)	0.001	0.999	0.000
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)	0.001	0.999	0.000
M62.80 Other specified disorders of muscle (Multiple sites)	0.001	0.999	0.000
M90.72 Fracture of bone in neoplastic disease (Upper arm)	0.001	0.999	0.000
S22.50 Flail chest (closed)	0.001	0.999	0.000
G59.8 Other mononeuropathies in diseases classified elsewhere	0.001	0.999	0.000
H44.0 Purulent endophthalmitis	0.001	0.999	0.000
M90.7 Fracture of bone in neoplastic disease	0.001	0.999	0.000
N94.9 Unspecified condition associated with female genital organs and menstrual cycle	0.001	0.999	0.000
Q82.8 Other specified congenital malformations of skin	0.001	0.999	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.001	0.999	0.000
Z43.5 Attention to cyctostomy	0.001	0.999	0.000
M80.59 Idiopathic osteoporosis with pathological fracture (Site unspecified)	0.001	0.999	0.000
M80.58 Idiopathic osteoporosis with pathological fracture (Other)	0.001	0.999	0.000
M80.57 Idiopathic osteoporosis with pathological fracture (Ankle and foot)	0.001	0.999	0.000
M80.56 Idiopathic osteoporosis with pathological fracture (Lower leg)	0.001	0.999	0.000
M80.55 Idiopathic osteoporosis with pathological fracture (Pelvic region and thigh)	0.001	0.999	0.000
M80.54 Idiopathic osteoporosis with pathological fracture (Hand)	0.001	0.999	0.000
M80.53 Idiopathic osteoporosis with pathological fracture (Forearm)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations